Literature DB >> 10487606

Tissue distribution and kinetics of endogenous porphyrins synthesized after topical application of ALA in different vehicles.

A Casas1, H Fukuda, A M Batlle.   

Abstract

The use of 5-aminolaevulinic acid (ALA) is gaining increasing attention for photosensitization in photodynamic therapy of superficially localized tumours. The aim of this work was to determine the kinetics of porphyrin generation in tissues after topical application of ALA delivered in different vehicles on the skin overlying the tumour and normal skin of mice. Maximal accumulation was found in tumour 3 h after ALA application in both cream and lotion preparations. Normal and overlying tumour skin tissues showed different kinetic patterns, reflecting histological changes when the latter is invaded by tumour cells. Liver, kidney, spleen and blood porphyrins also raised from basal levels, showing that ALA and/or ALA-induced porphyrins reach all tissues after topical application. During the first 24 h of ALA topical application, precursors and porphyrins are excreted by both urine and faeces. ALA lotion applied on the skin overlying the tumour induced higher accumulation of tumoural porphyrins than cream, and lotion applied on normal skin appeared to be the most efficient upon inducing total body porphyrins. This work has demonstrated the great influence of the formulation of ALA vehicle on penetration through the skin. Knowledge of the kinetics of porphyrin generation after different conditions of ALA application is needed for the optimization of diagnosis and phototherapy in human tumours.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487606      PMCID: PMC2374280          DOI: 10.1038/sj.bjc.6690644

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Clinical use of porphyrin ester cromatography of urine and feces.

Authors:  T K With
Journal:  Dan Med Bull       Date:  1975-02

2.  Porphyrin biosynthesis. Studies on the nature of a biosynthetic porphyrin and its identification with the so-called "208" porphyrin.

Authors:  A M DEL BATLLE; M GRINSTEIN
Journal:  Biochim Biophys Acta       Date:  1962-02-12

3.  Quantitation of hydrogen peroxide formed during UV-visible irradiation of protoporphyrin, coproporphyrin and uroporphyrin.

Authors:  I A Menon; M A Becker; S D Persad; H F Haberman
Journal:  Clin Chim Acta       Date:  1990-01-31       Impact factor: 3.786

4.  Further studies on the histamine metabolism in the M-2 adenocarcinoma.

Authors:  A J Scolnick; M C Rubio; L L Colombo; R R Comolli; R A Caro
Journal:  Biomed Pharmacother       Date:  1984       Impact factor: 6.529

5.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience.

Authors:  J C Kennedy; R H Pottier; D C Pross
Journal:  J Photochem Photobiol B       Date:  1990-06       Impact factor: 6.252

6.  Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light.

Authors:  T J Dougherty; G B Grindey; R Fiel; K R Weishaupt; D G Boyle
Journal:  J Natl Cancer Inst       Date:  1975-07       Impact factor: 13.506

7.  Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats.

Authors:  R Van Hillegersberg; J W Van den Berg; W J Kort; O T Terpstra; J H Wilson
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

Review 8.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy.

Authors:  J C Kennedy; R H Pottier
Journal:  J Photochem Photobiol B       Date:  1992-07-30       Impact factor: 6.252

9.  Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma.

Authors:  Q Peng; J Moan; T Warloe; J M Nesland; C Rimington
Journal:  Int J Cancer       Date:  1992-09-30       Impact factor: 7.396

10.  Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase.

Authors:  H A Dailey; A Smith
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

View more
  5 in total

1.  Autoradiographic and scintillation analysis of 5-aminolevulinic acid permeation through epithelialised tissue: implications for topical photodynamic therapy of superficial gynaecological neoplasias.

Authors:  Paul A McCarron; Ryan F Donnelly; A David Woolfson
Journal:  Pharm Res       Date:  2007-07-27       Impact factor: 4.200

2.  Oil components modulate the skin delivery of 5-aminolevulinic acid and its ester prodrug from oil-in-water and water-in-oil nanoemulsions.

Authors:  Li-Wen Zhang; Saleh A Al-Suwayeh; Chi-Feng Hung; Chih-Chieh Chen; Jia-You Fang
Journal:  Int J Nanomedicine       Date:  2011-04-05

3.  ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitization.

Authors:  A Casas; C Perotti; H Fukuda; L Rogers; A R Butler; A Batlle
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

4.  Topical application of ALA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: tissue distribution.

Authors:  C Perotti; A Casas; H Fukuda; P Sacca; A Batlle
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

5.  Derivatives of 5-aminolevulinic Acid for photodynamic therapy.

Authors:  Ryan F Donnelly; Paul A McCarron; A David Woolfson
Journal:  Perspect Medicin Chem       Date:  2007-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.